Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma – The early Australian experience

发表于 2026-7-17 18:15:40

期刊：European Journal of Cancer

文献作者：Francis Proulx-Rocray; Rebecca Symons; Yang Wang; Samrin Liaqat; Lydia Warburton; Claresta Jiang; Terence Wong; Edward Hsiao; Sydney Ch'ng; Kerwin F. Shannon; Michael Rtshiladze; Thomas E. Pennington; David J. Coker; Matteo S. Carlino; Andrew Spillane; Jonathan Stretch; Robyn P.M. Saw; Alexander C.J. van Akkooi; Hayden Snow; David E. Gyorki; Lavinia Spain; Louise A. Jackett; Victoria Atkinson; Rachel Roberts-Thomson; Marcin Dzienis; Adnan Khattak; Shahneen Sandhu; Robert V. Rawson; Serigne N. Lo; Georgina V. Long; Alexander M. Menzies

出版日期：2026-7-

DOI号：10.1016/j.ejca.2026.116865

下载链接：https://www.sciencedirect.com/sc ... 959804926006465/pdf

文献链接：https://doi.org/10.1016/j.ejca.2026.116865

当前文献来源于 Elsevier BV。

备注信息：

[Elsevier/Sciencedirect] Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma – The early Australian experience

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma – The early Australian experience 一键复制

发表回复

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma – The early Australian experience